Method Development, Validation and Transfer

Method Development, Validation and Transfer
Product Description

Kymos Pharma Services, S.L. offers wide range of chemistry, manufacturing & control analytical services in medicinal chemistry which includes method development, validation and transfer. Kymos has comprehensive knowledge in the development and validation of analytical proprietary and non-proprietary methods for excipients, apis, intermediate products and finished products, according to the ich q2 (r1) and fda guidelines and using qbd strategies to improve the results. Their methods are ready for transfer to contract-giver, in compliance with eu-gmp chapter 6, performing a comparative test, a co-validation in two sites or a revalidation. Contact us for more information.

Kymos Pharma Services, S.L.

  • ES
  • 2016
    On CPHI since
  • 100 - 249
    Employees
Company types
Contract Service
Specifications
  • Selling Points
    Product Features; Quality Service
  • Supplied from
    Spain

Kymos Pharma Services, S.L.

  • ES
  • 2016
    On CPHI since
  • 100 - 249
    Employees
Company types
Contract Service

More Products from Kymos Pharma Services, S.L. (4)

  • Bioanalysis of Small Molecules

    Product Bioanalysis of Small Molecules

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes bioanalysis of small molecules. Kymos offer bioanalytical method development and validation of innovative small molecules by mass spectrometry. It has the experience of being the selected partner for ...
  • Immunogenicity

    Product Immunogenicity

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes immunogenicity. Kymos have develops new bioanalytical methods for immunogenicity studies of proteins and peptides following ema and fda guidelines on immunogenicity of therapeutic proteins. Depending ...
  • Bioequivalence Studies

    Product Bioequivalence Studies

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes bioequivalence studies. Kymos are experts in bioanalysis for bioequivalence studies in collaboration with the sponsor and/or the selected clinical phase center. It has a long list of validated bioanal...
  • Percutaneous Absorption

    Product Percutaneous Absorption

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes percutaneous absorption. Kymos shows their experience in studies of percutaneous absorption for topical semisolid drug products using vertical diffusion cells (o franz cells). Both in vitro release te...

Kymos Pharma Services, S.L. resources (2)

  • News Kymos Acquires Germany’s Prolytic

    Kymos, a Contract Research Organisation (CRO) and member of CataloniaBio & HealthTech, has bought German company Prolytic GmbH in order to strengthen its activity in the biologics and advanced therapies market. The company previously acquired Italian firm Pharmaprogress in 2016.
  • Brochure KYMOS: Adding Value to Biopharma

    KYMOS recently had the pleasure to lead a TV program series about the importance of outsourcing service providers like ourselves in the provision of medicines. Since the outbreak of COVID-19 the general public is paying much more attention to the biopharmaceutical industry and the challenges of conducting drug development, manufacturing, quality control and supply in the midst of a global pandemic. We invite you to watch this 2-minute English video and celebrate society's rising awareness of the key role played by the pharma and biotech sectors in our day-to-day lives.